Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer

Platt-Higgins, Angela; Renshaw, Christine; West, Christopher R.; Winstanley, John; Rudland, Suzete de Silva; Barraclough, Roger; Rudland, Philip S.

doi:10.1002/(sici)1097-0215(20000320)89:2<198::aid-ijc16>3.0.co;2-l

Cited by 79 publications

(56 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…been reported that the high degree of S100A4 expression is correlated with a shorter prognosis in cases of cancer. In breast cancer, the expression of S100A4 was increased in the metastatic lesion (9,11,12). Moreover, it has also been reported that the expression of S100A4 is an indicator of lymph node metastasis and tumor recurrence in colorectal cancer.…”

Section: Discussionmentioning

confidence: 89%

“…S100A4 belongs to the S100 calcium binding protein family and may be characterized as a cytoplasmic protein that promotes cellular motility via direct interaction with myosin-IIA and also has functions in cell cycle progression. Its overexpression has been documented in breast (9)(10)(11)(12), gastric (13), colorectal (14)(15)(16), esophageal squamous cell (17) and gallbladder carcinoma (18), ovarian (19) and bladder cancer (20), papillary thyroid carcinoma (21,22) and non-small cell lung cancer (23). In addition, its upregulation has been associated with disease progression, metastasis and decreased patient survival.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Prognostic value of cytoplasmic expression of S100A4 protein in endometrial carcinoma

et al. 2014

View full text Add to dashboard Cite

Abstract. The S100A4 protein, a member of the S100 family of calcium-binding proteins, has been considered as a candidate prognostic marker in patients with cancer. The present study was conducted to evaluate the prognostic value of S100A4 and to examine its correlation with the clinicopathological parameters and the overall survival and progression-free survival in patients with endometrial carcinoma (EC). To do this, we performed immunohistochemistry of formalin-fixed tissue sections obtained from 135 cases of EC. In addition, we quantified the level of S100A4 mRNA using the quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR). The cytoplasmic expression of S100A4 protein was observed in 35 cases (25.9%). There was a significant association between the expression of S100A4 and clinicopathological parameters such as histologic grade, FIGO stage, lymph node metastasis and loss of progesterone receptor (PR). qRT-PCR demonstrated that the level of S100A4 mRNA was significantly higher in ECs as compared with normal endometrium. The cytoplasmic expression of S100A4 had a significant correlation with shorter overall survival and progression-free survival on the Kaplan-Meyer survival analysis. In multivariate analysis, there was a significant correlation between S100A4 expression and a poorer OS. In conclusion, our results indicate that S100A4 may be a biological marker indicating the recurrence and poor prognosis in patients with EC.

show abstract

Section: Discussionmentioning

confidence: 89%

Section: Introductionmentioning

confidence: 99%

Prognostic value of cytoplasmic expression of S100A4 protein in endometrial carcinoma

et al. 2014

View full text Add to dashboard Cite

show abstract

“…Stimulation of tumor metastasis was demonstrated in two transgenic mouse models with overexpression of the S100A4 gene Davies et al, 1996). In a number of human cancers of different origin, the enhanced expression of S100A4 was associated with poor prognosis (Platt-Higgins et al, 2000;Yonemura et al, 2000;Davies et al, 2002;Rosty et al, 2002). S100A4 protein belongs to the S100 family of Ca 2 þ -binding proteins.…”

Section: Introductionmentioning

confidence: 99%

Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity

et al. 2004

View full text Add to dashboard Cite

S100A4(mts1) protein expression has been strongly associated with metastatic tumor progression. It has been suggested as a prognostic marker for a number of human cancers. It is proposed that extracellular S100A4 accelerates cancer progression by stimulating the motility of endothelial cells, thereby promoting angiogenesis. Here we show that in 3D culture mouse endothelial cells (SVEC 4-10) respond to recombinant S100A4 by stimulating invasive growth of capillary-like structures. The outgrowth is not dependent on the stimulation of cell proliferation, but rather correlates with the transcriptional modulation of genes involved in the proteolytic degradation of extracellular matrix (ECM). Treatment of SVEC 4-10 with the S100A4 protein leads to the transcriptional activation of collagenase 3 (MMP-13) mRNA followed by subsequent release of the protein from the cells. b-Casein zymography demonstrates enhancement of proteolytic activity associated with MMP-13. This observation indicates that extracellular S100A4 stimulates the production of ECM degrading enzymes from endothelial cells, thereby stimulating the remodeling of ECM. This could explain the angiogenic and metastasis-stimulating activity of S100A4(mts1).

show abstract

“…The tight association of S100A4 with metastasis allows us to rate it among the most reliable prognostic markers. A high level of S100A4 in various types of cancers (breast, esophageal, gastric, colorectal, bladder, gallbladder, and lung) correlates with unfavorable prognosis and lethality (7)(8)(9)(10)(11). S100A4 belongs to the S100 family of Ca 2ϩ -binding proteins that comprises 20 members.…”

mentioning

confidence: 99%

Functional Significance of Metastasis-inducing S100A4(Mts1) in Tumor-Stroma Interplay

Schmidt-Hansen

Klingelhöfer

Grum-Schwensen

et al. 2004

Journal of Biological Chemistry

131

138

View full text Add to dashboard Cite

Causal implication of S100A4 in inducing metastases was convincingly shown previously. However, the mechanisms that associate S100A4 with tumor progression are not well understood. S100A4 protein, as a typical member of the S100 family, exhibits dual, intracellular and extracellular, functions. This work is focused on the extracellular function of S100A4, in particular its involvement in tumor-stroma interplay in VMR (mouse adenocarcinoma cell line) tumor cells, which exhibit stroma-dependent metastatic phenotype. We demonstrated the reciprocal influence of tumor and stroma cells where tumor cells stimulate S100A4 secretion from fibroblasts in culture. In turn, extracellular S100A4 modifies the cytoskeleton and focal adhesions and triggers several other events in tumor cells. We found stabilization of the tumor suppressor protein p53 and modulation of its function. In particular, extracellular S100A4 down-regulates the pro-apoptotic bax and the angiogenesis inhibitor thrombospondin-1 genes. For the first time, we demonstrate here that the S100A4 protein added to the extracellular space strongly stimulates proteolytic activity of VMR cells. This activity most probably is associated with matrix metalloproteinases and, in particular, with matrix metalloproteinase-13. Finally, the application of the recombinant S100A4 protein confers stroma-independent metastatic phenotype on VMR tumor cells. In conclusion, our results indicate that metastasis-inducing S100A4 protein plays a pivotal role in the tumor-stroma environment. S100A4 released either by tumor or stroma cells triggers pro-metastatic cascades in tumor cells.Metastatic dissemination of cancer cells results in incurable disease and becomes one of the leading causes of cancer patient deaths. Studies on genes and their protein products involved in this process are of great importance.Causal implication of S100A4 (mts1, CAPL, pEL98, Calvasculin, p9Ka, and FSP1) in metastatic tumor progression was demonstrated by several approaches. Transfection of rodent and human non-metastatic tumor cell lines with S100A4 converts their phenotype to metastatic cells, and contrariwise, the antisense-and ribozyme-mediated mts1-inactivation abolish the metastatic potential of metastatic tumor cells (1-4). Tumors developed in transgenic mice bearing exogenous S100A4 gene acquired metastatic phenotype (5, 6). The tight association of S100A4 with metastasis allows us to rate it among the most reliable prognostic markers. A high level of S100A4 in various types of cancers (breast, esophageal, gastric, colorectal, bladder, gallbladder, and lung) correlates with unfavorable prognosis and lethality (7-11). S100A4 belongs to the S100 family of Ca 2ϩ -binding proteins that comprises 20 members. They are involved in the regulation of various important cellular functions such as cell growth, cell-cell communication, energy metabolism, contraction, neurite outgrowth, and cell motility (for review see Refs. 12-14). S100A4 protein, as a typical member of the S100 family, exerts dual, intracellul...

show abstract

Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer

Cited by 79 publications

References 14 publications

Prognostic value of cytoplasmic expression of S100A4 protein in endometrial carcinoma

Prognostic value of cytoplasmic expression of S100A4 protein in endometrial carcinoma

Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity

Functional Significance of Metastasis-inducing S100A4(Mts1) in Tumor-Stroma Interplay

Contact Info

Product

Resources

About